BAFF selectively enhances the survival of plasmablasts generated from human memory B cells
- PMID: 12865416
- PMCID: PMC164292
- DOI: 10.1172/JCI18025
BAFF selectively enhances the survival of plasmablasts generated from human memory B cells
Erratum in
- J Clin Invest. 2004 Apr;113(7):1069
Abstract
The generation of Ig-secreting cells (ISCs) from memory B cells requires interactions between antigen-specific (Ag-specific) B cells, T cells, and dendritic cells. This process must be strictly regulated to ensure sufficient humoral immunity while avoiding production of pathogenic autoantibodies. BAFF, a member of the TNF family, is a key regulator of B cell homeostasis. BAFF exerts its effect by binding to three receptors - transmembrane activator of and CAML interactor (TACI), B cell maturation antigen (BCMA), and BAFF receptor (BAFF-R). To elucidate the contribution of BAFF to the differentiation of B cells into ISCs, we tracked the fate of human memory B cells stimulated with BAFF or CD40L. BAFF and CD40L significantly increased the overall number of surviving B cells. This was achieved via distinct mechanisms. CD40L induced proliferation of nondifferentiated blasts, while BAFF prevented apoptosis of ISCs without enhancing proliferation. The altered responsiveness of activated memory B cells to CD40L and BAFF correlated with changes in surface phenotype such that expression of CD40 and BAFF-R were reduced on ISCs while BCMA was induced. These results suggest BAFF may enhance humoral immunity in vivo by promoting survival of ISCs via a BCMA-dependent mechanism. These findings have wide-ranging implications for the treatment of human immunodeficiencies as well as autoimmune diseases.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/164292/bin/JCI0318025.f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/164292/bin/JCI0318025.f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/164292/bin/JCI0318025.f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/164292/bin/JCI0318025.f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/164292/bin/JCI0318025.f5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/164292/bin/JCI0318025.f6.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/164292/bin/JCI0318025.f7.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/164292/bin/JCI0318025.f8.gif)
Similar articles
-
BAFF, APRIL and their receptors: structure, function and signaling.Semin Immunol. 2006 Oct;18(5):263-75. doi: 10.1016/j.smim.2006.04.006. Epub 2006 Aug 17. Semin Immunol. 2006. PMID: 16914324 Review.
-
Identification of proteoglycans as the APRIL-specific binding partners.J Exp Med. 2005 May 2;201(9):1375-83. doi: 10.1084/jem.20042309. Epub 2005 Apr 25. J Exp Med. 2005. PMID: 15851487 Free PMC article.
-
The BAFF/APRIL system: life beyond B lymphocytes.Mol Immunol. 2005 May;42(7):763-72. doi: 10.1016/j.molimm.2004.06.041. Epub 2004 Dec 8. Mol Immunol. 2005. PMID: 15829264 Review.
-
Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.Biochemistry. 2005 Feb 15;44(6):1919-31. doi: 10.1021/bi048227k. Biochemistry. 2005. PMID: 15697217
-
B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.Mol Cell Biol. 2001 Jun;21(12):4067-74. doi: 10.1128/MCB.21.12.4067-4074.2001. Mol Cell Biol. 2001. PMID: 11359913 Free PMC article.
Cited by
-
Tissue-specific sex differences in pediatric and adult immune cell composition and function.Front Immunol. 2024 May 15;15:1373537. doi: 10.3389/fimmu.2024.1373537. eCollection 2024. Front Immunol. 2024. PMID: 38812520 Free PMC article.
-
Sarcoidosis-related autoimmune inflammation in COVID-19 convalescent patients.Front Med (Lausanne). 2023 Dec 21;10:1271198. doi: 10.3389/fmed.2023.1271198. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38179278 Free PMC article. Review.
-
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial.Ann Rheum Dis. 2024 Mar 12;83(4):475-487. doi: 10.1136/ard-2023-224854. Ann Rheum Dis. 2024. PMID: 38129117 Free PMC article. Clinical Trial.
-
Transcriptome analysis of renal ischemia/reperfusion (I/R) injury in BAFF and BAFF-R deficient mice.PLoS One. 2023 Sep 26;18(9):e0291619. doi: 10.1371/journal.pone.0291619. eCollection 2023. PLoS One. 2023. PMID: 37751458 Free PMC article.
-
Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma.NPJ Precis Oncol. 2023 Sep 18;7(1):95. doi: 10.1038/s41698-023-00446-0. NPJ Precis Oncol. 2023. PMID: 37723227 Free PMC article.
References
-
- Van Kooten C, Banchereau J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 1996;61:1–77. - PubMed
-
- Liu YJ, Banchereau J. The paths and molecular controls of peripheral B-cell development. The Immunologist. 1996;4:55–66.
-
- Agematsu K, et al. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood. 1998;91:173–180. - PubMed
-
- Stuber E, Neurath M, Calderhead D, Fell HP, Strober W. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity. 1995;2:507–521. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous